Description
Drug Utilization Review Board Meeting Agenda 1.9.26
Objective
The Committee serves in an advisory capacity to the New Mexico Health Care
Authority/Medical Assistance Division, to perform reviews and make recommendations
which facilitate the development and maintenance of the New Mexico Preferred Drug List
for the Combined Pharmaceutical and Therapeutics and the Drug Utilization Review.
Including but not limited to recommending structured, ongoing review of practitioner
prescribing, pharmacist dispensing, and patient use of medication. In addition to
recommending agents to be added to the state unified PDL. Operate with transparency
and provide clinical guidance for Medicaid formularies per the Center for Medicare &
Medicaid Services (CMS) mandate.
Materials
Document